Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Terpos

Showing results (31-40 of 101) with videos related to

Pageof 11
Sort By:
Hematological Oncology|July 2, 2005
The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro-vessel density but not serum levels of angiogenic cytokines in patients with refractory/relapsed multiple myelomaE Hatjiharissi, E Terpos, M Papaioannou, et al.
Kidney International|February 28, 2006
Early markers of renal dysfunction in patients with sickle cell/beta-thalassemiaE Voskaridou, E Terpos, S Michail, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|April 22, 2010
Zoledronic acid-induced transient hepatotoxicity in a patient effectively treated for Paget's disease of boneS A Polyzos, J Kountouras, A D Anastasilakis, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|June 19, 2009
Efficacy and safety of denosumab in postmenopausal women with osteopenia or osteoporosis: a systematic review and a meta-analysisA D Anastasilakis, K A Toulis, D G Goulis, et al.
Leukemia|October 4, 2013
Progressive changes in chromatin structure and DNA damage response signals in bone marrow and peripheral blood during myelomagenesisM Gkotzamanidou, E Terpos, C Bamia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2012
Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post-lenalidomide and dexamethasone therapyE Terpos, E Kastritis, D Christoulas, et al.
Blood Cancer Journal|November 12, 2016
Overexpression of RANKL by invariant NKT cells enriched in the bone marrow of patients with multiple myelomaE Spanoudakis, M Papoutselis, E Terpos, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 7, 2013
Circulating periostin levels do not differ between postmenopausal women with normal and low bone mass and are not affected by zoledronic acid treatmentA D Anastasilakis, S A Polyzos, P Makras, et al.
Bone Marrow Transplantation|March 7, 2003
Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patientsE Terpos, J F Apperley, D Samson, et al.
Haematologia|September 5, 1998
Severe aplastic anaemia relapsing during a pregnancy; spontaneous remission following terminationJ Meletis, M Samarkos, S Mesogitis, et al.
Pageof 11

Showing results (31-40 of 101) with videos related to

Sort By:
Pageof 11
Hematological Oncology|July 2, 2005
The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro-vessel density but not serum levels of angiogenic cytokines in patients with refractory/relapsed multiple myelomaE Hatjiharissi, E Terpos, M Papaioannou, et al.
Kidney International|February 28, 2006
Early markers of renal dysfunction in patients with sickle cell/beta-thalassemiaE Voskaridou, E Terpos, S Michail, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|April 22, 2010
Zoledronic acid-induced transient hepatotoxicity in a patient effectively treated for Paget's disease of boneS A Polyzos, J Kountouras, A D Anastasilakis, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|June 19, 2009
Efficacy and safety of denosumab in postmenopausal women with osteopenia or osteoporosis: a systematic review and a meta-analysisA D Anastasilakis, K A Toulis, D G Goulis, et al.
Leukemia|October 4, 2013
Progressive changes in chromatin structure and DNA damage response signals in bone marrow and peripheral blood during myelomagenesisM Gkotzamanidou, E Terpos, C Bamia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2012
Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post-lenalidomide and dexamethasone therapyE Terpos, E Kastritis, D Christoulas, et al.
Blood Cancer Journal|November 12, 2016
Overexpression of RANKL by invariant NKT cells enriched in the bone marrow of patients with multiple myelomaE Spanoudakis, M Papoutselis, E Terpos, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 7, 2013
Circulating periostin levels do not differ between postmenopausal women with normal and low bone mass and are not affected by zoledronic acid treatmentA D Anastasilakis, S A Polyzos, P Makras, et al.
Bone Marrow Transplantation|March 7, 2003
Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patientsE Terpos, J F Apperley, D Samson, et al.
Haematologia|September 5, 1998
Severe aplastic anaemia relapsing during a pregnancy; spontaneous remission following terminationJ Meletis, M Samarkos, S Mesogitis, et al.
Pageof 11